RESUMEN
INTRODUCTION: Periostin, an extracellular matrix protein, plays an important role in osteogenesis and is also known to activate several signals that contribute to chondrogenesis. The absence of periostin in periostin knockout mice leads to several disorders such as craniosynostosis and periostitis. There are several splice variants with different roles in heart disease and myocardial infarction. However, little is known about each variant's role in chondrogenesis, followed by bone formation. Therefore, the aim of this study is to investigate the role of several variants in chondrogenesis differentiation and bone formation in the craniofacial region. Periostin splice variants included a full-length variant (Control), a variant lacking exon 17 (ΔEx17), a variant lacking exon 21 (ΔEx21), and another variant lacking both exon 17 and 21 ***(ΔEx17&21). MATERIALS AND METHODS: We used C56BL6/N mice (n = 6) for the wild type (Control)*** and the three variant type mice (n = 6 each) to identify the effect of each variant morphologically and histologically. Micro-computed tomography demonstrated a smaller craniofacial skeleton in ΔEx17s, ΔEx21s, and ΔEx17&21s compared to Controls, especially the mandibular bone. We, thus, focused on the mandibular condyle. RESULTS: The most distinctive histological observation was that each defected mouse appeared to have more hypertrophic chondrocytes than Controls. Real-time PCR demonstrated the differences among the group. Moreover, the lack of exon 17 or exon 21 in periostin leads to inadequate chondrocyte differentiation and presents in a diminutive craniofacial skeleton. DISCUSSION: Therefore, these findings suggested that each variant has a significant role in chondrocyte hypertrophy, leading to suppression of bone formation.
Asunto(s)
Condrocitos , Condrogénesis , Animales , Ratones , Huesos , Diferenciación Celular/genética , Condrocitos/metabolismo , Condrogénesis/genética , Hipertrofia/genética , Hipertrofia/metabolismo , Hipertrofia/patología , Ratones Noqueados , Osteogénesis/genética , Microtomografía por Rayos XRESUMEN
OBJECTIVE: Hypertrophy-like changes are often observed in chondrocytes during the development of osteoarthritis (OA). These changes play a crucial part in the OA-associated cartilage degradation and osteophyte formation. However, the pathogenesis leading to such changes is still unknown. In this study, we investigated the mechanism by which these hypertrophy-like changes are induced from the viewpoint of impaired glycolytic metabolism. METHODS: The effect of sodium fluoride (NaF) on glycolytic metabolism of cultured chondrocytes was confirmed by measurement of intracellular adenosine triphosphate (ATP) production. Translocation of phosphorylated Smad1/5/8 to the nucleus was evaluated by subcellular fractionation and Western blotting. Chondrocyte hypertrophy-like changes were investigated by real-time RT-PCR and Western blot analysis of differentiation markers. RESULTS: ATP production was dose-dependently decreased by NaF in the human chondrocytic cell line HCS-2/8. In addition, both chondrocyte proliferation and differentiation were inhibited, whereas cell death was promoted by treatment with NaF. Interestingly, combinational treatment with NaF and lactate enhanced translocation of phospho-Smad1/5/8 to the nucleus, as well as gene expression of ALP, VEGF, COL10a1, and matrix metalloproteinase13 (MMP13), which were the markers of late mature and hypertrophic chondrocytes. Furthermore, the production of type X collagen and activation of MMP9 were also promoted under the same conditions. CONCLUSIONS: These findings suggest that decreased ATP production by NaF promotes hypertrophy-like changes via activation of phospho-Smad1/5/8 in the presence of lactate. Novel metabolic aspects of OA pathogenesis are indicated herein.
Asunto(s)
Condrocitos/metabolismo , Proteínas Smad Reguladas por Receptores/metabolismo , Adenosina Trifosfato/biosíntesis , Proteínas Morfogenéticas Óseas/metabolismo , Muerte Celular/efectos de los fármacos , Diferenciación Celular/efectos de los fármacos , Núcleo Celular/metabolismo , Proliferación Celular/efectos de los fármacos , Células Cultivadas , Condrocitos/efectos de los fármacos , Condrocitos/patología , Relación Dosis-Respuesta a Droga , Combinación de Medicamentos , Glucólisis/efectos de los fármacos , Glucólisis/fisiología , Humanos , Hipertrofia/inducido químicamente , Hipertrofia/metabolismo , FN-kappa B/metabolismo , Transducción de Señal/efectos de los fármacos , Proteína Smad1/metabolismo , Proteína Smad5/metabolismo , Proteína Smad8/metabolismo , Fluoruro de Sodio/administración & dosificación , Fluoruro de Sodio/farmacología , Lactato de Sodio/farmacologíaRESUMEN
The presentation of development-relevant bioactive cues by biomaterial scaffolds is essential to the guided differentiation of seeded human mesenchymal stem cells (hMSCs) and subsequent tissue regeneration. Wnt5a is a critical non-canonical Wnt signaling ligand and plays a key role in the development of musculoskeletal tissues including cartilage. Herein we investigate the efficacy of biofunctionalizing the hyaluronic acid hydrogel with a synthetic Wnt5a mimetic ligand (Foxy5 peptide) to promote the chondrogenesis of hMSCs and the potential underlying molecular mechanism. Our findings show that the conjugation of Foxy5 peptide in the hydrogels activates non-canonical Wnt signaling of encapsulated hMSCs via the upregulation expression of PLCE1, CaMKII-ß, and downstream NFATc1, leading to enhanced expression of chondrogenic markers such as SOX9. The decoration of Foxy5 peptide also promotes the metabolic activities of encapsulated hMSCs as evidenced by upregulated gene expression of mitochondrial complex components and glucose metabolism biomarkers, leading to enhanced ATP biosynthesis. Furthermore, the conjugation of Foxy5 peptide activates the non-canonical Wnt, PI3K-PDK-AKT and IKK/NF-κB signaling pathways, thereby inhibiting the hypertrophy of the chondrogenically induced hMSCs in the hydrogels under both in vitro and in vivo conditions. This enhanced chondrogenesis and attenuated hypertrophy of hMSCs by the biomaterial-mediated bioactive cue presentation facilitates the potential clinical translation of hMSCs for cartilage regeneration. Our work provides valuable guidance to the rational design of bio-inductive scaffolds for various applications in regenerative medicine.
Asunto(s)
Condrogénesis , Células Madre Mesenquimatosas , Materiales Biocompatibles/metabolismo , Diferenciación Celular , Células Cultivadas , Humanos , Hidrogeles/química , Hipertrofia/metabolismo , Ligandos , Péptidos/química , Células Madre/metabolismo , Vía de Señalización Wnt , Proteína Wnt-5a/metabolismoRESUMEN
Fluoride at high doses is a well-known toxic agent for the musculoskeletal system, primarily in bone and cartilage cells. Research on fluoride toxicity concerning particularly on the skeletal muscle is scanty. We hypothesized that during skeletal fluorosis, along with bone, muscle is also affected, so we have evaluated the effects of Sodium fluoride (NaF) on mouse skeletal muscles. Sodium fluoride (80 ppm) was administered to 5-week-old C57BL6 mice drinking water for 15 and 60 days, respectively. We carried out histology, primary culture, molecular and proteomic analysis of fluoride administered mouse skeletal muscles. Results indicated an increase in the muscle mass (hypertrophy) in vivo and myotubes ex vivo by activating the IGF1/PI3/Akt/mTOR signalling pathway due to short term NaF exposure. The long-term exposure of mice to NaF caused loss of muscle proteins leading to muscle atrophy due to activation of the ubiquitin-proteasome pathway. Differentially expressed proteins were characterized and mapped using a proteomic approach. Moreover, the factors responsible for protein synthesis and PI3/Akt/mTOR pathway were upregulated, leading to muscle hypertrophy during the short term NaF exposure. Long term exposure to NaF resulted in down-regulation of metabolic pathways. Elevated myostatin resulted in the up-regulation of the muscle-specific E3 ligases-MuRF1, promoting the ubiquitination and proteasome-mediated degradation of critical sarcomeric proteins.
Asunto(s)
Agua Potable , Fluoruro de Sodio , Animales , Fluoruros/toxicidad , Hipertrofia/inducido químicamente , Hipertrofia/metabolismo , Hipertrofia/patología , Ratones , Ratones Endogámicos C57BL , Músculo Esquelético/metabolismo , Atrofia Muscular/inducido químicamente , Atrofia Muscular/metabolismo , Atrofia Muscular/patología , Complejo de la Endopetidasa Proteasomal/metabolismo , Proteómica , Proteínas Proto-Oncogénicas c-akt/metabolismo , Fluoruro de Sodio/metabolismo , Fluoruro de Sodio/toxicidad , Serina-Treonina Quinasas TOR/metabolismoRESUMEN
OBJECTIVE: Despite numerous existing treatments for keloids, the responses in the clinic have been disappointing, due to either low efficacy or side effects. Numerous studies dealing with preclinical and clinical trials have been published about effective therapies for fibrotic diseases using mesenchymal stem cells; however, no research has yet been reported to scientifically investigate the effect of human dental pulp stem cells (HDPSCs) on the treatment of keloids. The objective is to provide an experimental basis for the application of stem cells in the treatment of keloids. METHODS: Human normal fibroblasts (HNFs) and human keloid fibroblasts (HKFs) were cultured alone and in combination with HDPSCs using a transwell cell-contact-independent cell culture system. The effects of HDPSCs on HKFs were tested using a CCK-8 assay, live/dead staining assay, quantitative polymerase chain reaction, Western blot and immunofluorescence microscopy. RESULTS: HDPSCs did not inhibit the proliferation nor the apoptosis of HKFs and HNFs. HDPSCs did, however, inhibit their migration. Furthermore, HDPSCs significantly decreased the expression of profibrotic genes (CTGF, TGF-ß1 and TGF-ß2) in HKFs and KNFs (p < 0.05), except for CTGF in HNFs. Moreover, HDPSCs suppressed the extracellular matrix (ECM) synthesis in HKFs, as indicated by the decreased expression of collagen I as well as the low levels of hydroxyproline in the cell culture supernatant (p < 0.05). CONCLUSIONS: The co-culture of HDPSCs inhibits the migration of HKFs and the expression of pro-fibrotic genes, while promoting the expression of anti-fibrotic genes. HDPSCs' co-culture also inhibits the synthesis of the extracellular matrix by HKFs, whereas it does not affect the proliferation and apoptosis of HKFs. Therefore, it can be concluded that HDPSCs can themselves be used as a tool for restraining/hindering the initiation or progression of fibrotic tissue.
Asunto(s)
Cognición/fisiología , Hipertrofia/metabolismo , Queloide/metabolismo , Células Madre/citología , Adulto , Bioensayo/métodos , Pulpa Dental/metabolismo , Matriz Extracelular/metabolismo , Femenino , Fibroblastos/metabolismo , Humanos , MasculinoRESUMEN
Myostatin (GDF-8) is a member of the transforming growth factor-beta (TGF-beta) superfamily that is highly expressed in skeletal muscle, and myostatin loss-of-function leads to doubling of skeletal muscle mass. Myostatin-deficient mice have been used as a model for studying muscle-bone interactions, and here we review the skeletal phenotype associated with altered myostatin signaling. It is now known that myostatin is a key regulator of mesenchymal stem cell proliferation and differentiation, and mice lacking the myostatin gene show decreased body fat and a generalized increase in bone density and strength. The increase in bone density is observed in most anatomical regions, including the limbs, spine, and jaw, and myostatin inhibitors have been observed to significantly increase bone formation. Myostatin is also expressed in the early phases of fracture healing, and myostatin deficiency leads to increased fracture callus size and strength. Together, these data suggest that myostatin has direct effects on the proliferation and differentiation of osteoprogenitor cells, and that myostatin antagonists and inhibitors are likely to enhance both muscle mass and bone strength.
Asunto(s)
Desarrollo Óseo/fisiología , Músculo Esquelético/crecimiento & desarrollo , Músculo Esquelético/metabolismo , Desarrollo Musculoesquelético/fisiología , Miostatina/metabolismo , Animales , Densidad Ósea/fisiología , Enfermedades Óseas Metabólicas/genética , Enfermedades Óseas Metabólicas/metabolismo , Enfermedades Óseas Metabólicas/fisiopatología , Regeneración Ósea/genética , Modelos Animales de Enfermedad , Humanos , Hipertrofia/genética , Hipertrofia/metabolismo , Células Madre Mesenquimatosas/citología , Células Madre Mesenquimatosas/metabolismo , Ratones , Músculo Esquelético/citología , Miostatina/genéticaRESUMEN
The aim of the present study was to compare oxidative stress biomarkers determined in blood and saliva before and after acute resistance exercise. 1 week after 1 maximum repetition (1RM) test 11 healthy well-trained males completed a hypertrophy acute session of resistance training including 3 sets of 10 repetitions at 75% of the 1RM, with 90 s rest periods between sets. Venous blood and saliva samples were collected before (pre) and 10 min after (post) the resistance training session. A significant (p<0.05) rise in blood lactate accumulation (pre: 1.6+/-0.4 vs. post: 9.5+/-2.4) was found post-acute resistance training compared with baseline values. Significant increases (p<0.05) in TBARS (42%), AOPP (28%), uric acid (27%) and GSH (14%) were detected post-acute resistance training in relation to pre in blood samples. A significant increase (p<0.05) in uric acid (36%) was found in saliva post-acute resistance training as well as a significant correlation (p<0.05) between uric acid determined in blood and saliva. Statistical analysis did not reveal any other change in the salivary oxidative stress biomarkers. In conclusion, an acute session of resistance exercise induces oxidative stress in plasma of trained men after acute resistance training, which was not found in saliva samples except for uric acid.
Asunto(s)
Biomarcadores/metabolismo , Estrés Oxidativo , Entrenamiento de Fuerza , Adulto , Antioxidantes/metabolismo , Humanos , Hipertrofia/metabolismo , Masculino , Saliva/metabolismo , Adulto JovenRESUMEN
Adenoidal hypertrophy (AH) is a common disorder in the pediatric population, with common symptoms including mouth breathing, nasal congestion, hyponasal speech, snoring and obstructive sleep apnea. Although the pathogenesis of AH has not been fully elucidated, recent studies have indicated that immune responses may play an important role in AH. Tumor necrosis factor-alpha (TNF-α)-induced protein-8 like-2 (TIPE2) is a newly identified protein that negatively regulates the activation of inflammatory pathways. Here, we investigated the effect of TIPE2 in AH in children. We observed that the levels of TNF-α and interleukin-6 were greater in the adenoid tissue of AH children than in healthy control subjects (P < 0.01), and this increase was positively correlated with the severity of AH. The level of TIPE2 expression was decreased compared with control and was negatively correlated with AH. TIPE2 overexpression in primary human monocytes (isolated from adenoid tissue of children with AH) inhibited the activation of nuclear factor-κB and the expression of TNF-α and interleukin-6. These results suggest that overexpression of TIPE2 may attenuate AH through inactivation of the nuclear factor-κB signaling pathway.
Asunto(s)
Tonsila Faríngea/patología , Péptidos y Proteínas de Señalización Intracelular/metabolismo , Tonsila Faríngea/metabolismo , Niño , Preescolar , China , Femenino , Humanos , Hipertrofia/metabolismo , Inflamación/inmunología , Interleucina-6/metabolismo , Péptidos y Proteínas de Señalización Intracelular/genética , Masculino , Monocitos/metabolismo , ARN Mensajero/metabolismo , Transducción de Señal/genética , Factor de Necrosis Tumoral alfa/metabolismoRESUMEN
PURPOSE: The purpose of this study was to assess bone growth and blood flow in the condylar region in patients with unilateral condylar hyperactivity (UCH) by use of positron emission tomography (PET). PATIENTS AND METHODS: This prospective study included 7 patients with UCH and a control group of 6 volunteers. In addition to normal clinical investigations, labeled fluoride ((18)F(-)) and oxygen 15-labeled water (H(2)(15)O) PET scans were performed. RESULTS: In control subjects the net rate of fluoride influx, representing bone metabolism, was similar for left and right condylar sides. Interestingly, this was not significantly different from the affected condyles in UCH patients. Rather, the net rate of fluoride influx on the contralateral side of UCH patients was reduced significantly compared with the affected side (P= .02) and control subjects (P= .004). The mean blood flow on the left and right condylar sides in control subjects was not significantly different. The same was true for the hyperactive and contralateral condyles of UCH patients. Blood flow in the condylar region in UCH patients was similar to that in the control group. CONCLUSIONS: There was no evidence of an abnormally high rate of bone growth in the affected condylar region in UCH patients. Instead, the rate of bone growth appeared to be reduced in the contralateral condylar region. These PET results are in contrast to the characteristic clinical picture of UCH patients and suggest the possibility of subgroups in patients with a mandibular asymmetry caused by UCH. Furthermore, no evidence of hypervascularization of the condylar region in UCH patients was found.
Asunto(s)
Asimetría Facial/diagnóstico por imagen , Cóndilo Mandibular/metabolismo , Cóndilo Mandibular/patología , Articulación Temporomandibular/diagnóstico por imagen , Adolescente , Adulto , Estudios de Casos y Controles , Femenino , Radioisótopos de Flúor , Humanos , Hipertrofia/metabolismo , Modelos Lineales , Masculino , Cóndilo Mandibular/irrigación sanguínea , Cóndilo Mandibular/diagnóstico por imagen , Radioisótopos de Oxígeno , Tomografía de Emisión de Positrones , Estudios Prospectivos , Adulto JovenRESUMEN
The surrounding medium of periodontal pathogen Porphyromonas gingivalis (P. gingivalis) increased cardiomyocyte hypertrophy and apoptosis whereas Actinobaeillus actinomycetemcomitans and Prevotella intermedia had no effects. The purpose of this study is to clarify the role of p38 pathway in P. gingivalis conditioned medium-induced H9c2 myocardial cell hypertrophy and apoptosis. DNA fragmentation, cellular morphology, nuclear condensation, p38 protein products, and mitochondrial-dependent apoptotic related proteins in cultured H9c2 myocardial cell were measured by agarose gel electrophoresis, immunofluorescence, DAPI, and western blotting following P. gingivalis conditioned medium and/or pre-administration of SB203580 (p38 inhibitor). The p38 protein products and associated activities in H9c2 cells were both upregulated by P. gingivalis conditioned medium. P. gingivalis conditioned medium increased cellular sizes, DNA fragmentation, nuclear condensation, mitochondrial Bcl2-associated death promoter (Bad), cytosolic cytochrome c (cyt c), and the activated form of caspase-9 proteins in H9c2 cells. The increased cellular sizes, DNA fragmentation, nuclear condensation, Bad, cyt c, and caspase-9 activities of H9c2 cells treated with P. gingivalis conditioned medium were all significantly reduced after pre-administration of SB203580. Our findings suggest that the activity of p38 signal pathway may be initiated by P. gingivalis conditioned medium and further activate mitochondrial-dependent apoptotic pathways leading to cell death in cultured H9c2 myocardial cells.
Asunto(s)
Apoptosis/efectos de los fármacos , Medios de Cultivo Condicionados/farmacología , Miocitos Cardíacos/efectos de los fármacos , Porphyromonas gingivalis/química , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo , Western Blotting , Caspasa 9/efectos de los fármacos , Caspasa 9/metabolismo , Células Cultivadas , Citocromos c/efectos de los fármacos , Citocromos c/metabolismo , Citosol/efectos de los fármacos , Citosol/enzimología , Fragmentación del ADN/efectos de los fármacos , Humanos , Hipertrofia/inducido químicamente , Hipertrofia/metabolismo , Imidazoles/farmacología , Indoles/química , Miocitos Cardíacos/metabolismo , Piridinas/farmacología , Regulación hacia Arriba/efectos de los fármacos , Proteína Letal Asociada a bcl/efectos de los fármacos , Proteína Letal Asociada a bcl/metabolismo , Proteínas Quinasas p38 Activadas por Mitógenos/biosíntesis , Proteínas Quinasas p38 Activadas por Mitógenos/efectos de los fármacosRESUMEN
Mesenchymal stem cells (MSCs) are pluripotent progenitor cells with the ability to generate cartilage, bone, muscle, tendon, ligament, and fat. However, recent evidence indicates that a major drawback of current cartilage- and intervertebral disc-tissue engineering is that human MSCs isolated from some arthritic patients (a clinically relevant source of stem cells) express type X collagen (a marker of chondrocyte hypertrophy associated with endochondral ossification) and osteogenic markers. Some studies have attempted to use growth factors to inhibit type X collagen expression, but none has addressed the possible effect of the chemical composition of the substratum on chondrocyte hypertrophy and osteogenesis. Here, we examine the growth and differentiation potential of human MSCs cultured on nitrogen (N)-rich plasma polymer layers (N-doped plasma-polymerized ethylene, containing up to 36% nitrogen; PPE:N). We show that PPE:N almost completely suppresses the expression not only of type X collagen, but also of osteogenic marker genes such as alkaline phosphatase, bone sialoprotein, and osteocalcin. In contrast, neither aggrecan nor type I collagen expression were significantly affected. These results indicate that PPE:N coatings may be suitable surfaces for inducing MSCs to a chondrocyte or disc-like phenotype for tissue engineering of cartilage or intervertebral discs, in which hypertrophy and osteogenesis are suppressed.
Asunto(s)
Condrocitos/metabolismo , Materiales Biocompatibles Revestidos , Regulación hacia Abajo , Células Madre Mesenquimatosas/metabolismo , Osteogénesis , Células Madre Pluripotentes/metabolismo , Polietileno , Anciano , Anciano de 80 o más Años , Antígenos de Diferenciación/biosíntesis , Artritis/genética , Artritis/patología , Diferenciación Celular/genética , Condrocitos/patología , Condrogénesis/genética , Colágeno Tipo X/biosíntesis , Femenino , Humanos , Hipertrofia/genética , Hipertrofia/metabolismo , Hipertrofia/patología , Masculino , Células Madre Mesenquimatosas/patología , Persona de Mediana Edad , Células Madre Pluripotentes/patología , Ingeniería de TejidosRESUMEN
This study was an investigation of the role of cholecystokinin (CCK) in the stimulatory action of cholestyramine on rat exocrine pancreas. Postprandial CCK release was significantly enhanced by acute administration of cholestyramine (12.7 +/- 1.8 vs 3.7 +/- 0.5 pmol/L in controls). Over four weeks, rats were fed either regular diet or diet containing 6% cholestyramine, and were treated with the specific CCK receptor antagonist L-364,718 (2 x 0.5 mg/kg body weight/day s.c.) or DMSO (vehicle for the antagonist). Cholestyramine significantly increased pancreatic weight and trypsin and chymotrypsin contents. L-364,718 abolished these effects. Concomitant administration of antagonist and cholestyramine elevated amylase content, compared to controls. CCK levels in fasted animals did not differ between the four groups. The effect of the same dose of L-364,718 on pancreatic enzyme depletion, induced by the protease inhibitor camostate, was studied in a control experiment. A single dose of camostate (200 mg/kg) caused a 44-68% decrease in enzyme content. L-364,718 reversed this effect for all enzymes. We conclude that CCK is the mediator of cholestyramine-induced pancreatic hypertrophy and increase in content of proteases. After long-term administration, the CCK receptor antagonist, in combination with cholestyramine revealed an agonistic effect on individual, pancreatic enzyme content.
Asunto(s)
Colecistoquinina/fisiología , Resina de Colestiramina/farmacología , Gabexato/análogos & derivados , Páncreas/efectos de los fármacos , Administración Oral , Animales , Benzodiazepinonas/farmacología , Colecistoquinina/antagonistas & inhibidores , Colecistoquinina/sangre , Resina de Colestiramina/administración & dosificación , Quimotripsina/metabolismo , ADN/metabolismo , Devazepida , Dimetilsulfóxido/farmacología , Relación Dosis-Respuesta a Droga , Ésteres , Guanidinas/efectos adversos , Guanidinas/farmacología , Hipertrofia/inducido químicamente , Hipertrofia/metabolismo , Hipertrofia/patología , Masculino , Tamaño de los Órganos/efectos de los fármacos , Páncreas/enzimología , Páncreas/patología , Ratas , Ratas Endogámicas , Receptores de Colecistoquinina/efectos de los fármacos , Factores de Tiempo , Tripsina/metabolismo , Inhibidores de Tripsina/efectos adversos , Inhibidores de Tripsina/farmacologíaRESUMEN
The identification of a gain-of-function mutation in CACNA1C as the cause of Timothy Syndrome (TS), a rare disorder characterized by cardiac arrhythmias and syndactyly, highlighted unexpected roles for the L-type voltage-gated Ca2+ channel CaV1.2 in nonexcitable cells. How abnormal Ca2+ influx through CaV1.2 underlies phenotypes such as the accompanying syndactyly or craniofacial abnormalities in the majority of affected individuals is not readily explained by established CaV1.2 roles. Here, we show that CaV1.2 is expressed in the first and second pharyngeal arches within the subset of cells that give rise to jaw primordia. Gain-of-function and loss-of-function studies in mouse, in concert with knockdown/rescue and pharmacological approaches in zebrafish, demonstrated that Ca2+ influx through CaV1.2 regulates jaw development. Cranial neural crest migration was unaffected by CaV1.2 knockdown, suggesting a role for CaV1.2 later in development. Focusing on the mandible, we observed that cellular hypertrophy and hyperplasia depended upon Ca2+ signals through CaV1.2, including those that activated the calcineurin signaling pathway. Together, these results provide new insights into the role of voltage-gated Ca2+ channels in nonexcitable cells during development.
Asunto(s)
Canales de Calcio Tipo L/fisiología , Mandíbula/embriología , Proteínas de Pez Cebra/fisiología , Animales , Trastorno Autístico , Región Branquial/embriología , Región Branquial/metabolismo , Región Branquial/patología , Calcineurina/metabolismo , Canales de Calcio Tipo L/genética , Canales de Calcio Tipo L/metabolismo , Señalización del Calcio , Movimiento Celular , Células Cultivadas , Embrión de Mamíferos/metabolismo , Embrión no Mamífero/metabolismo , Expresión Génica , Técnicas de Silenciamiento del Gen , Corazón/embriología , Humanos , Hiperplasia/embriología , Hiperplasia/genética , Hiperplasia/metabolismo , Hipertrofia/embriología , Hipertrofia/genética , Hipertrofia/metabolismo , Síndrome de QT Prolongado/genética , Mandíbula/metabolismo , Mandíbula/patología , Ratones , Ratones de la Cepa 129 , Ratones Endogámicos C57BL , Morfolinos/genética , Mutación Missense , Cresta Neural/metabolismo , Células Madre/metabolismo , Células Madre/fisiología , Sindactilia/genética , Pez Cebra , Proteínas de Pez Cebra/genética , Proteínas de Pez Cebra/metabolismoRESUMEN
Isoproterenol-induced salivary polypeptides (IISP), a group of proline-rich proteins synthesized by mouse parotids, have been considered as markers for isoproterenol-induced parotid hypertrophy. Rodents fed diets containing high-tannin cereals (sorghum), also develop parotid hypertrophy. To test whether tannins are directly involved in provoking sialotrophic growth, we studied the effect of intraperitoneal and topical oral administrations of tannic acid (TA) on the induction of IISP polypeptides in endogamic mice (A/Snell). TA was characterized by HPLC chromatography and spectral analysis and shown to be composed solely of gallotannins, a complex family of glucose and gallic acid esters. IISP polypeptides were monitored in saliva by SDS-polyacrylamide gel electrophoresis during 36 h after ending TA stimulation. Single daily intraperitoneal administrations of TA for 3 consecutive days (0.033 mg/g bw/day), at variance of parallel administrations of isoproterenol (0.042 mg/g bw/day) failed to induce IISP polypeptides. However, repeated topical applications of TA into the mouse mouths (1.21 mg/g bw divided into three equal doses given at 4-h intervals within a single day) resulted in unequivocal induction of IISP polypeptides. That response was clearly intensified by increasing the stimulation frequency to eight equivalent doses given at 1.5-h intervals within a single day (corresponding to 3.23 mg/g bw) and even further by repeating this protocol for 3 days. Under these productive schemes of stimulations by TA, electrophoretic fractionation of parotid homogenates showed new polypeptide bands migrating in parallel to salivary IISP. These results suggest that topically administered gallotannins are effective inducers of trophic growth in mouse parotids.
Asunto(s)
Taninos Hidrolizables/farmacología , Enfermedades de las Parótidas/metabolismo , Enfermedades de las Parótidas/patología , Péptidos/metabolismo , Saliva/efectos de los fármacos , Saliva/metabolismo , Taninos/farmacología , Administración Oral , Administración Tópica , Animales , Femenino , Taninos Hidrolizables/administración & dosificación , Taninos Hidrolizables/química , Hipertrofia/inducido químicamente , Hipertrofia/metabolismo , Hipertrofia/patología , Inyecciones Intraperitoneales , Masculino , Ratones , Estructura Molecular , Enfermedades de las Parótidas/inducido químicamente , Taninos/administración & dosificación , Taninos/químicaRESUMEN
The study was carried out on 16 cases of mixed thyroid hypertrophy in which total or partial thyroidectomy was performed. Fragments collected intraoperatively from the thyroid nodule were used for extraction of high polymerized DNA. At the same time with quantitative evaluation of DNA, RNA and proteins were also assayed. The thermic transition mean temperature of the DNA extracted from the thyroid nodule is compared to other standards (DNA-HP-standard, calf thymus DNA, normal leukocytic DNA) and the thermic transition curves are presented. Hyperchromicity after thermic denaturation and renaturation is analysed and expressed in per cent values.
Asunto(s)
ADN/metabolismo , Calor , Polímeros/metabolismo , Glándula Tiroides/metabolismo , ADN/análisis , ADN/aislamiento & purificación , Humanos , Hipertrofia/metabolismo , Polímeros/análisis , Polímeros/aislamiento & purificación , Temperatura , Enfermedades de la Tiroides/metabolismoRESUMEN
The effect of periodic amputations of the lower incisors of the rat on the electrolyte concentration in the major salivary glands was studied. The incisor amputations caused a hypertrophy of the parotid, submandibular and sublingual glands. The resulting increased weight of the salivary glands was due to a higher dry mass. In general, the electrolyte concentration showed higher values in the salivary gland tissues of the incisor-amputated animals. Considering the parotid, submandibular and sublingual glands respectively, the Na+ concentration was increased by 47%, 50% and 14%; and Mg2+ concentration by 377%, 126+ and 376%. Inorganic phosphorus increased 45% in the parotid, 25% in the subnamdibular and was unchanged in the sublingual gland. K+ concentration increased in the submandibular (12%) and sublingual (100%) glands but decreased in the parotid (24%). The Na+/k+ ratio was higher in the parotid (82%) and submandibular (37%) glands and lower in the sublingual gland (84%). The electrolyte concen-ration changes are discussed in relation to the mechanism and type of stimulation promoted by the incisor-amputations on the major salivary glands of the rat.